1. The power and potential of doxorubicin‐DNA adducts;Cutts;IUBMB Life,2005
2. Chemotherapy induced cardiomyopathy: pathogenesis, monitoring cardiomyopathy: pathogenesis, monitoring and management;Shakir;J. Clin. Med. Res.,2009
3. Doxorubicin-induced cardiomyopathy;Singal;N. Engl. J. Med.,1998
4. Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function;De Angelis;Circulation,2010
5. Carvedilol post-infarct survival controlled evaluation (CAPRICORN): a multinational, randomized, double blind study on the effects of carvedilol on mortality and morbidity in patients with left ventricular dysfunction after MI;Dargie,2001